CATAFLAM
Live / Registered — Registered (as of 11 May 2021)
What this means for you
Registered since 11 May 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88713451
- Registration number
- 6349240
- Mark type
- Stylized text
- Filed
- 03 Dec 2019
- Published for opposition
- 11 Aug 2020
- Registered
- 11 May 2021
- Attorney of record
- Timothy D. Pecsenye
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparation for the treatment of articular syndrome, degenerative and chronic inflammatory disease of musculoskeletal system, post-traumatic inflammation of soft tissue and muscluloskeletal system, pain in the spine, neuralgia, myalgia, arthralgia, pain and inflammation after surgery or injury, pain in gout, migraine, algomenorrhea, pain with Bursitis, proctitis, colic (biliary and renal), pain in infectious and inflammatory diseases of ENT organs, and inhibition of miosis during ocular surgery
Owner
- AMICI PHARMA, INC., MELVILLE, NY, US
- Amici Pharmaceuticals, LLC, Melville, NY, US
- Amici Pharmaceuticals, LLC, Melville, NY, US
- Amici Pharmaceuticals, LLC, Melville, NY, US
Prosecution history
- 22 Aug 2024 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 11 May 2021 — REGISTERED-PRINCIPAL REGISTER
- 09 Apr 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 08 Apr 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 24 Mar 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 03 Mar 2021 — USE AMENDMENT FILED
- 22 Mar 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 03 Mar 2021 — TEAS STATEMENT OF USE RECEIVED
- 06 Oct 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 11 Aug 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 11 Aug 2020 — PUBLISHED FOR OPPOSITION
- 22 Jul 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Jul 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 15 Jun 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 15 Jun 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE